EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Applying Machine Learning for Antibiotic Development and Prediction of Microbial Resistance

Apurva Panjla iD, Saurabh Joshi, Geetanjali Singh, Sarah E Bamford iD, Adam Mechler, Sandeep Verma iD

Chemistry – An Asian Journal · 2024

DOI: 10.1002/asia.202400102 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry – An Asian Journal, 2024. Verfasst von Apurva Panjla und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur, 208016, UP, India. Hauptthemen laut MEDLINE: Machine Learning, Anti-Bacterial Agents, Drug Discovery. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Australian Government, Australian National Fabrication Facility (ANFF), Center of Excellence in Antimicrobial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) poses a serious threat to human health worldwide. It is now more challenging than ever to introduce a potent antibiotic to the market considering rapid emergence of antimicrobial resistance, surpassing the rate of antibiotic drug discovery. Hence, new approaches need to be developed to accelerate the rate of drug discovery process and meet the demands for new antibiotics, while reducing the cost of their development. Machine learning holds immense promise of becoming a useful tool, especially since in the last two decades, exponential growth has occurred in computational power and biological big data analytics. Recent advancements in machine learning algorithms for drug discovery have provided significant clues for potential antibiotic classes. Apart from discovery of new scaffolds, the machine learning protocols will significantly impact prediction of AMR patterns and drug metabolism. In this review, we outline power of machine learning in antibiotic drug discovery, metabolic fate, and AMR prediction to support researchers engaged and interested in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningAnti-Bacterial AgentsDrug DiscoveryHumansDrug Resistance, MicrobialDrug Resistance, BacterialBacteria

Stichwörter der Autor:innen

Antimicrobial resistanceantibioticsantimicrobial peptidemachine learning

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur, 208016, UP, India.
  • Department of Chemistry and Physics, La Trobe University, Bundoora, Victoria, 3086, Australia.
  • Mehta Family Center for Engineering in Medicine, Center for Nanoscience, Gangwal School of Medical Sciences and Technology, Indian Institute of Technology Kanpur, Kanpur, 208016, UP, India.

ORCID-Profile: Apurva Panjla, Sarah E Bamford, Sandeep Verma

Förderung

  • Australian Government
  • Australian National Fabrication Facility (ANFF)
  • Center of Excellence in Antimicrobial Research
  • JC Bose National Fellowship
  • Ministry of Education
  • MHRD
  • CSIR India
  • Prime Minister's Research Fellowship, India

Zitieren

APA

Panjla, A., Joshi, S., Singh, G., Bamford, S. E., Mechler, A., & Verma, S. (2024). Applying Machine Learning for Antibiotic Development and Prediction of Microbial Resistance. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.202400102

Vancouver

Panjla A, Joshi S, Singh G, Bamford SE, Mechler A, Verma S. Applying Machine Learning for Antibiotic Development and Prediction of Microbial Resistance. Chemistry – An Asian Journal. 2024. doi:10.1002/asia.202400102

BibTeX
@article{Panjla2024,
  author = {Panjla, Apurva and Joshi, Saurabh and Singh, Geetanjali and Bamford, Sarah E and Mechler, Adam and Verma, Sandeep},
  title = {Applying Machine Learning for Antibiotic Development and Prediction of Microbial Resistance},
  journal = {Chemistry – An Asian Journal},
  year = {2024},
  doi = {10.1002/asia.202400102}
}
Kostenlos starten →